5 Interactions found for:
Drug Interactions
No drug interactions were found for selected drugs: Lasix, potassium chloride.
This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Drug and Food Interactions
Moderate
Lasix
+ Food
The following applies to the ingredients: Furosemide (found in Lasix)
Furosemide and ethanol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. These side effects are most likely to be seen at the beginning of treatment, following a dose increase, or when treatment is restarted after an interruption. Let your doctor know if you develop these symptoms and they do not go away after a few days or they become troublesome. Avoid driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and Pregnancy Interactions
Major
Lasix
+ Pregnancy
The following applies to the ingredients: Furosemide (found in Lasix)
Professional Content
This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus; use is contraindicated according to some authorities.
AU TGA pregnancy category: C
US FDA pregnancy category: C
Comments: Use of this drug during pregnancy requires monitoring of electrolytes, hematocrit, and fetal growth.
Animal studies have revealed evidence of fetolethality. There are no controlled data in human pregnancy.
AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
References
- "Product Information. Lasix (furosemide)." sanofi-aventis PROD (2007):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Minor
Potassium Chloride
+ Pregnancy
The following applies to the ingredients: Potassium Chloride
Professional Content
This drug should be used during pregnancy only if clearly needed. Use under physician supervision.
AU TGA pregnancy category: Exempt
US FDA pregnancy category: Not assigned
Comments:
-Pregnancy is associated with gastrointestinal hypomotility; solid forms of oral potassium should be given only if clearly needed.
-Close monitoring of serum potassium is recommended.
-Potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm.
Animal studies showed no adverse effects on embryofetal development. There are no controlled data in human pregnancy. It is considered unlikely that supplementation that does not lead to hyperkalemia would adversely affect the fetus. The background birth defect and miscarriage risk for the indicated population is not known. In the US general population, the estimated major birth defect risk is 2 to 4% and the miscarriage risk is 15 to 20%.
AU Exempt: Medications exempted from pregnancy classification are not absolutely safe for use in pregnancy in all circumstances. Some exempted medicines, for example the complementary medicine, St John's Wort, may interact with other medicines and induce unexpected adverse effects in the mother and/or fetus.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
References
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Klor-Con M10 (potassium chloride)." Upsher-Smith Laboratories Inc (2016):
- "Product Information. Klor-Con (potassium chloride)." Upsher-Smith Laboratories Inc (2016):
- "Product Information. Micro-K (potassium chloride)." Ther-Rx Corporation (2016):
- "Product Information. Potassium Chloride (potassium chloride)." Pharmaceutical Assoc Inc Div Beach Products (2016):
- "Product Information. K-Tab (potassium chloride)." AbbVie US LLC (2016):
- "Product Information. Potassium Chloride ER (potassium chloride)." Zydus Pharmaceuticals (USA) Inc (2018):
- "Product Information. Potassium Chloride In Dextrose and S (LVP solution with potassium)." B Braun Medical Inc, Irvine, CA.
Drug and Breastfeeding Interactions
Major
Lasix
+ Breastfeeding
The following applies to the ingredients: Furosemide (found in Lasix)
Professional Content
Caution is recommended as use is contraindicated according to some authorities.
Excreted into human milk: Yes
Comments: The effects in the nursing infant are unknown.
References
- "Product Information. Lasix (furosemide)." sanofi-aventis PROD (2007):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Minor
Potassium Chloride
+ Breastfeeding
The following applies to the ingredients: Potassium Chloride
Professional Content
Use is generally considered acceptable; benefit to mother should outweigh risk to the infant. Use under the supervision of a physician.
Excreted into human milk: Yes
Comments:
-As long as body potassium is not excessive, potassium supplementation should have little or no effect on the level in human milk.
-Normal potassium ion levels in human breast milk is about 13 mEq/L.
-There is no information regarding this drug on the effects on a breastfed infant or effects on milk production.
-Consider the developmental and health benefits of breastfeeding along with the mother's clinical need for this medication as well as any potential adverse effects from this drug or the underlying maternal condition.
References
- Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins (1998):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Klor-Con M10 (potassium chloride)." Upsher-Smith Laboratories Inc (2016):
- "Product Information. Klor-Con (potassium chloride)." Upsher-Smith Laboratories Inc (2016):
- "Product Information. Micro-K (potassium chloride)." Ther-Rx Corporation (2016):
- "Product Information. Potassium Chloride (potassium chloride)." Pharmaceutical Assoc Inc Div Beach Products (2016):
- "Product Information. K-Tab (potassium chloride)." AbbVie US LLC (2016):
- "Product Information. Potassium Chloride ER (potassium chloride)." Zydus Pharmaceuticals (USA) Inc (2018):
- "Product Information. Potassium Chloride In Dextrose and S (LVP solution with potassium)." B Braun Medical Inc, Irvine, CA.
Therapeutic Duplication Warnings
No warnings were found for your selected drugs.Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Switch to: Professional Interactions
Drug Interaction Classification | |
---|---|
These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication. |
|
Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Unknown | No interaction information available. |
Disclaimer: This content should not be considered complete and should not be used in place of a call or visit to a healthcare professional. Use of this content is subject to our terms of use & medical disclaimer.